What to know about How well do COVID antivirals actually work? Not as well as we thought
The article discusses new research regarding the effectiveness of COVID-19 antivirals, Paxlovid and Lagevrio, in the context of increased population immunity. It compares results from randomized controlled trials and observational studies to suggest that the benefits of these treatments may be diminishing.
Propaganda risk10%
Claims checked13
Techniques found0
Topics0
Coverage spectrum
Coverage gap: Low Left coverage
Left0%
Center100%
Right0%
6 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.
What happened
If you’re aged over 70, or over 50 with underlying health conditions, and have tested positive for COVID, you might have been offered free or subsidised antivirals.
Why it matters
Earlier in the pandemic, these medicines were an important way to reduce the chance of people becoming severely ill with COVID, needing to be hospitalised, or dying.
Common ground
But our new research suggests that with high levels of vaccination and immunity from previous infections, COVID antivirals are no longer working as well.
Perspective signals
No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.
Follow-up questions
What concrete event or decision sits underneath the headline: How well do COVID antivirals actually work? Not as well as we thought?
What evidence would most clearly confirm or weaken the claim that Three quarters of deaths were among people aged 80 and over?
What should readers watch for in the next update to know whether the story is changing?
The article discusses new research regarding the effectiveness of COVID-19 antivirals, Paxlovid and Lagevrio, in the context of increased population immunity. It compares results from randomized controlled trials and observational studies to suggest that the benefits of these treatments may be diminishing.
Low risk. This article shows minimal use of propaganda techniques.
fact_checkClaims Checked
eFinder analyzed this article and checked 13 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.
infoSingle Source4
schedulePending3
check_circleCorroborated3
helpInsufficient Evidence2
verifiedVerified By Reference1
help
Claim 1: “Three quarters of deaths were among people aged 80 and over.”
INSUFFICIENT EVIDENCE
No evidence was found or provided for this claim.
schedule
Claim 2: “Paxlovid can also interact with other drugs, causing serious reactions. It should be avoided, or the dose adjusted, in people with severe liver or kidney disease because it can make these conditions worse.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 3: “Paxlovid and Lagevrio work by stopping SARS-CoV-2 from replicating.”
CORROBORATED
While the specific search results for claim 2 were corrupted with irrelevant content, the search results for claim 3 explicitly state that 'Lagevrio and Paxlovid are designed to interfere with the virus’ ability to multiply', which confirms they stop replication.
web search
NEUTRAL
— Jilbab photos & videos. EroMe is the best place to share your erotic pics and porn videos. Every day, thousands of people use EroMe to enjoy free photos and videos. Come share your amateur horny...
https://www.erome.com/search?q=jilbab
Claim 4: “A course of treatment cost the government around A$1,100 from 2022 to 2025, much more than the treatment for influenza, oseltamivir (Tamiflu), which is only around $40.”
SINGLE SOURCE
The provided evidence mentions general costs (e.g., $2,054 in the US) but does not provide the specific Australian government cost of A$1,100 vs A$40 for oseltamivir between 2022-2025.
travel_explore
web search
NEUTRAL
— Paxlovid significantly reduces severe COVID-19 risk, while Lagevrio offers moderate protection. Here's how they compare in effectiveness and use.How much do Paxlovid and Lagevrio cost? As an emergency…
https://www.verywellhealth.com/lagevrio-molnupiravir-vs-paxl…
web search
NEUTRAL
— #PAXLOVID #LAGEVRIO #MolnupiravirHi everyone, I hope everyone in the States had a good Thanksgiving!This week's regular update is on the two upcoming COVID p...compensation from any pharmaceutical com…
https://www.youtube.com/watch?v=kkhX8ZPJwMk
info
Claim 5: “Between mid-2022 and mid-2025 the Australian government spent more than $2 billion on Paxlovid and Lagevrio.”
SINGLE SOURCE
No evidence was provided in the search results regarding the total expenditure of $2 billion by the Australian government on these drugs.
travel_explore
web search
NEUTRAL
— How Effective Are Lagevrio and Paxlovid? Lagevrio is available under the Food and Drug Administration's (FDA) emergency use authorization (EUA). Paxlovid, on the other hand, has received full approval…
https://www.verywellhealth.com/lagevrio-molnupiravir-vs-paxl…
travel_explore
web search
NEUTRAL
— Paxlovid (nirmatrelvir and ritonavir) and Lagevrio (molnupiravir) are two oral treatment options for mild-to-moderate coronavirus disease 2019 (COVID-19) in people who are at high risk for severe COVI…
https://www.drugs.com/paxlovid.html
travel_explore
web search
NEUTRAL
— Pfizer's COVID-19 pill, Paxlovid, appears to have a lot of positives, including an 89% reduction in the risk of hospitalization and death in clinical trials. Yale Medicine experts answer commonly aske…
https://www.yalemedicine.org/news/13-things-to-know-paxlovid…
check_circle
Claim 6: “In 2021, two industry-sponsored clinical trials reported promising results. One was for nirmatrelvir-ritonavir (Paxlovid), which reported an 89% reduction in severe illness. The other was a trial of molnupiravir (Lagevrio), which reported a 30% reduction.”
CORROBORATED
Multiple independent web sources confirm the 2021 clinical trial results: Paxlovid reporting an 89% reduction in severe illness and Lagevrio reporting a 30% reduction.
menu_book
wikipedia
NEUTRAL
— COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 throu…
https://en.wikipedia.org/wiki/COVID-19_drug_development
menu_book
wikipedia
NEUTRAL
— The PANORAMIC trial (short for Platform Adaptive Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community) is a clinical trial in the United Kingdom testing the effectiveness of new …
https://en.wikipedia.org/wiki/PANORAMIC_trial
Claim 7: “When SARS-CoV-2, the virus that causes COVID, first emerged in late 2019, no treatment was available.”
VERIFIED BY REFERENCE
Wikipedia and multiple web sources confirm that SARS-CoV-2 emerged in late 2019 and caused a pandemic; it is a well-established fact that no specific antiviral treatments existed at the moment of emergence.
menu_book
wikipedia
NEUTRAL
— Since the beginning of the COVID-19 pandemic, there have been efforts by scientists, governments, and others to determine the origin of the SARS-CoV-2 virus. Similar to other outbreaks, the virus was …
https://en.wikipedia.org/wiki/Origin_of_SARS-CoV-2
menu_book
wikipedia
NEUTRAL
— Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic that began in late 2019. The virus pre…
https://en.wikipedia.org/wiki/SARS-CoV-2
menu_book
wikipedia
NEUTRAL
— Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to la…
https://en.wikipedia.org/wiki/Variants_of_SARS-CoV-2
+ 3 more evidence sources
info
Claim 8: “COVID went from being the leading cause of death worldwide in 2021 to the 20th in 2023”
SINGLE SOURCE
The search results for this claim returned irrelevant adult content and did not provide global mortality rankings for 2021 and 2023.
travel_explore
web search
NEUTRAL
— Watch Arab Moroccan porn videos for free, here on Pornhub.com. Discover the growing collection of high quality Most Relevant XXX movies and clips. No other sex tube is more popular and features more A…
https://www.pornhub.com/video/search?search=arab+moroccan
travel_explore
web search
NEUTRAL
— Morocco Porn Videos: WATCH FREE here! مغربية تمارس الجنس بالدراجة تقول لماذا أنت وترتاح؟ أنا من يهتم بك. نحن خائفون منه، لذا من فضلك تعال إلي💦🇲🇦💦🇲🇦
https://pornkai.com/videos?q=morocco
travel_explore
web search
NEUTRAL
— 246.9k 100%10min - 1080p Video of an Algerian whore in Morocco fucking with her Moroccan boyfriend, hot Moroccan sex 13.9M 100%7min - 1080p morocco pawg pov big cock cum inside white ass homemade amat…
https://xnxx.health/search/hits/morocco
schedule
Claim 9: “The rates of COVID-related hospitalisations so far this year have been lower than last year, with 839 admissions at “sentinel hospitals”... in the first half of this year. This compares to 1,740 in the same period last year.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 10: “Both drugs became available in Australia and were listed on the Pharmaceutical Benefits Scheme (PBS) in early and mid-2022.”
CORROBORATED
Multiple sources confirm that both Paxlovid and Lagevrio were approved for sale on the Australian Pharmaceutical Benefits Scheme (PBS).
travel_explore
web search
NEUTRAL
— Lagevrio and Paxlovid are designed to interfere with the virus’ ability to multiply and clinical trials showed they reduced the risk of hospitalisation or death in COVID-19 patients at high risk of pr…
https://www.smh.com.au/politics/federal/antivirals-under-the…
travel_explore
web search
NEUTRAL
— Paxlovid is now available on the Pharmaceutical Benefits Scheme for certain high-risk patients with Covid. If taken in the first five days, antivirals such as Paxlovid can can prevent Covid from devel…
https://www.theguardian.com/australia-news/2022/may/02/peopl…
travel_explore
web search
NEUTRAL
— Antivirals are being developed around the world in a bid to combat the effects of COVID, but, for now, two antiviral pills have been approved for sale on the Pharmaceutical Benefits Scheme (PBS): Paxl…
https://www.brisbanetimes.com.au/national/what-are-covid-ant…
help
Claim 11: “There were 2,227 deaths involving COVID in 2025. This is more than the 1,784 deaths involving influenza.”
INSUFFICIENT EVIDENCE
No evidence was found or provided for this claim.
schedule
Claim 12: “Australia’s independent Pharmaceutical Benefits Advisory Committee (PBAC) is set to review COVID antivirals later in 2026.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 13: “In 2025, there were: 186,000 cases of COVID reported, 178,000 cases of RSV, 503,000 cases of influenza.”
SINGLE SOURCE
The provided evidence contains general links to Worldometer and WHO but does not list the specific 2025 case numbers for COVID, RSV, and influenza in Australia.
travel_explore
web search
NEUTRAL
— Daily and weekly updated statistics tracking the number of COVID-19 cases, recovered, and deaths. Historical data with cumulative charts, graphs, and updates.
https://www.worldometers.info/coronavirus/
web search
NEUTRAL
— Johns Hopkins experts in global public health, infectious disease, and emergency preparedness have been at the forefront of the international response to COVID-19.
https://coronavirus.jhu.edu/map.html
infoDisclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.